(19)
(11) EP 4 771 189 A2

(12)

(88) Date of publication A3:
01.05.2025

(43) Date of publication:
08.07.2026 Bulletin 2026/28

(21) Application number: 24861096.6

(22) Date of filing: 30.08.2024
(51) International Patent Classification (IPC): 
C12Q 1/6886(2018.01)
G16B 20/00(2019.01)
A61K 39/395(2006.01)
G16B 40/20(2019.01)
(52) Cooperative Patent Classification (CPC):
C07K 16/2818; A61K 2039/505; A61K 2039/507; G01N 2800/52; G01N 33/57585
(86) International application number:
PCT/US2024/044572
(87) International publication number:
WO 2025/049838 (06.03.2025 Gazette 2025/10)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 01.09.2023 US 202363536127 P

(71) Applicant: Apricity Health, Inc.
Houston, Texas 77019 (US)

(72) Inventors:
  • O'HAGAN, Ronan
    Arlington, Massachusetts 02476 (US)
  • CHIN, Lynda
    Houston, Texas 77019 (US)

(74) Representative: Forresters IP LLP 
Skygarden Erika-Mann-Straße 11
80636 München
80636 München (DE)

   


(54) DYNAMIC PROTEIN SIGNATURE TO PREDICT NON-RESPONSE TO IMMUNE CHECKPOINT INHIBITOR THERAPY